Resistance of novel mouse strains different in MHC class I and the NKC domain to the development of experimental tumors.
To elucidate the immunological mechanisms critical for tumor progression, we bred novel mouse strains, different in the NKC and H-2D domains. We used inbreeding to generate hybrids of Balb/c and C57BL/6 of stable H-2Db+d-NK1.1neg and H-2Db-d+NK1.1high phenotypes. We analyzed the growth of three established MHC class I-deficient tumor cell lines: TC-1/A9 tumor (HPV-associated) and B16F10 melanoma, both syngeneic to C57BL/6, and the MCB8 (3-methycholanthrene-induced tumor) syngeneic to Balb/c. Furthermore, we induced colorectal carcinoma by azoxymethane-DSS treatment to test the susceptibility to chemically-induced primary cancer. We found that the novel strains spontaneously regressed the tumor transplants syngeneic to both Balb/c (MCB8) and C57BL/6 (B16F10 and TC-1/A9) mice. The H2-Db+d-NK1.1neg, but not the H2-Db-d+NK1.1high strain was also highly resistant to chemically-induced colorectal cancer in comparison to the parental mice. The immune changes during TC-1/A9 cancer development involved an increase of the NK cell distribution in the peripheral blood and spleen along with higher expression of NKG2D activation antigen; this was in correlation with the time-dependent rise of cytotoxic activity in comparison to C57BL/6 mice. The TC-1/A9 cancer regression was accompanied by higher proportion of B cells in the spleen and B220+/CD86+ activated antigen-presenting B cells distributed in the lymphoid organs, as well as in the periphery. The changes in the T-cell population were represented mainly by the prevalence of T helper cells reflected by grown CD4/CD8 ratio, most prominent in the b+d-NK1.1neg strain. The results of the present study imply usefulness of the two novel mouse strains as an experimental model for further studies of tumor resistance mechanisms.
Department of Health Care Disciplines and Population Protection, Czech Technical University in Prague, Faculty of Biomedical Engineering, Sportovců 2311, 27201 Kladno, Czech Republic.
Anna
A
Fišerová
Department of Health Care Disciplines and Population Protection, Czech Technical University in Prague, Faculty of Biomedical Engineering, Sportovců 2311, 27201 Kladno, Czech Republic.
Jan
J
Richter
Department of Health Care Disciplines and Population Protection, Czech Technical University in Prague, Faculty of Biomedical Engineering, Sportovců 2311, 27201 Kladno, Czech Republic.
Katarína
K
Čapková
Department of Transgenic Models of Diseases, Institute of Molecular Genetics of the AS CR, v.v.i., Prague, Czech Centre for Phenogenomics, Division BIOCEV, Průmyslová 595, 252 42 Vestec, Czech Republic.
Jana
J
Bieblová
Department of Transgenic Models of Diseases, Institute of Molecular Genetics of the AS CR, v.v.i., Prague, Czech Centre for Phenogenomics, Division BIOCEV, Průmyslová 595, 252 42 Vestec, Czech Republic.
Romana
R
Mikyšková
Department of Transgenic Models of Diseases, Institute of Molecular Genetics of the AS CR, v.v.i., Prague, Czech Centre for Phenogenomics, Division BIOCEV, Průmyslová 595, 252 42 Vestec, Czech Republic.
Milan
M
Reiniš
Department of Transgenic Models of Diseases, Institute of Molecular Genetics of the AS CR, v.v.i., Prague, Czech Centre for Phenogenomics, Division BIOCEV, Průmyslová 595, 252 42 Vestec, Czech Republic.
Marie
M
Indrová
D000818:Animals; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D015395:Histocompatibility Antigens Class I / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology* / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D055655:NK Cell Lectin-Like Receptor Subfamily K / Q000096:biosynthesis / Q000276:immunology; D009374:Neoplasms, Experimental / Q000235:genetics* / Q000276:immunology / Q000473:pathology
D015395:Histocompatibility Antigens Class I; C527086:Klrk1 protein, mouse; D055655:NK Cell Lectin-Like Receptor Subfamily K